| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |